ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
12 Nov 2020

A Successful Rights Issue with Focus on Sales!

Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Success...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
12 Nov 2020

En framgångsrik emission med fokus på försäljning!

Press release (MAR) Malmö, 12 november, 2020 Acarix AB (publ) publicerar delårsrapport, januari – september 20...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2019

Acarix AB (publ) publishes Interim Report, January – September 2019

Malmö, November 14, 2019 Acarix finalized a rights issue to finance further market expansion In September we announced a rig...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2019

Acarix AB (publ) publicerar delårsrapport, januari – september 2019

Malmö den 14 november 2019 Acarix genomförde en företrädesemission för fortsatt marknadsexpansion Nylige...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2018

Kundutvärdering av CADScor®System ger positivt resultat jämfört med befintliga metoder

Delårsrapport januari-september 2018Malmö den 14 november 2018Kundutvärdering av CADScor®System gerpositivt resulta...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2018

Customer evaluation of CADScor®System compares favorably against existing methods

Interim Report, January - September 2018Malmö, November 14, 2018Customer evaluation of CADScor®Systemcompares favorably agains...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2017

Delårsrapport, januari – september 2017: CADScor®System lanserat på ytterligare viktiga marknader

PressmeddelandeMalmö, 14 november 2017Delårsrapport, januari - september 2017: CADScor®System lanserat på ytterlig...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2017

Interim report, January – September 2017: CADScor®System launched in additional key markets

Press releaseMalmö, November 14, 2017Interim report, January - September 2017: CADScor®System launched in additional key marke...
Continue reading
  • 1
  • 2

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.